Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study

NCT00212810 is registered in ClinicalTrials.gov with Ortho-McNeil Neurologics, Inc. as lead sponsor.

NCT NCT00212810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study
Lead sponsor
Ortho-McNeil Neurologics, Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
August 31, 2007
Enrollment
385 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

classic migraine, common migraine, headache, migraine